Cathie Wood is still buying Teladoc shares: here’s why


Cathie Wood is still buying Teladoc shares: here’s why

Ad disclosure

Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >


Wajeeh Khan

Apr 29, 2022

Cathie Wood loaded up on another $20 million worth of Teladoc shares.

She defends her bullish outlook for TDOC on CNBC’s “The Exchange”.

Shares of the telemedicine company are now down 65% for the year.

Shares of Teladoc Health Inc (NYSE: TDOC) have been in a freefall this year, now down roughly 65% for the year. Still, who continues to see value in the world’s largest telemedicine company is Cathie Wood.

Wood’s bull case for Teladoc shares

The influential investor loaded up on another $20 million worth of TDOC, after the stock crashed 40% on disappointing Q1 results earlier this week. Explaining why on CNBC’s “The Exchange”, she said:

Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

Our point of view is that Teladoc is becoming the healthcare information backbone of the U.S. It serves 16% of Americans are paid users, and we look for 15% to 20% range for an S-curve. As a trend moves into that market share, that’s the beginning of an S-curve.

Over the next five to ten years, Wood is convinced Teladoc will emerge as a “category killer” – one of the biggest stories in healthcare.

Wood isn’t bothered by weakness in DTC

The billionaire investor agreed that direct-to-consumer helped propel the overall business during the COVID pandemic, but said business-to-business was the “real story” in Teladoc.

Nobody mentioned the New York tri-state area hospital system that Teladoc won from another entity. What was also not mentioned is Amazon’s decision to partner with Teladoc as opposed to compete with it.

Through her family of Ark exchange-traded funds (ETFs), Wood now owns over 11% of the multinational virtual healthcare company. TDOC market cap has now shrunk to under $5.50 billion.

Invest in crypto, stocks, ETFs & more in minutes with our preferred broker,


68% of retail CFD accounts lose money

Visit site

Health & pharmaceuticals


North America

Stocks & Shares




Generated by Feedzy